PHARMATHENE, INC 4
4 · PHARMATHENE, INC · Filed Jan 31, 2014
Insider Transaction Report
Form 4
MORGES WAYNE
VP, Regulatory Affairs & Qual
Transactions
- Award
Stock Option (right to buy)
2014-01-29+190,000→ 190,000 totalExercise: $1.94Exp: 2024-01-29→ Common Stock (190,000 underlying)
Footnotes (2)
- [F1]The option vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
- [F2]On January 29, 2014, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.94 per share.